Therapeutic benefits in thalassemic mice transplanted with long term cultured bone marrow cells

Por Hatada, Seigo, Walton, William, Hatada, Tomoko, Wofford, Anne, Fox, Raymond, Liu, Naiyou, Lill, Michael C., Fair, Jeffery H., Kirby, Suzanne L., Smithies, Oliver
Publicado em 2010

Estimating Demand and Unmet Need for Allogeneic Hematopoietic Cell Transplantation in the United States Using Geographic Information Systems

Por Besse, Kelsey L., Preussler, Jaime M., Murphy, Elizabeth A., Denzen, Ellen M., Lill, Michael C., Chell, Jeffrey W., Senneka, Mary K., Majhail, Navneet S., Williams, Eric P.
Publicado no J Oncol Pract (2015)

SIMILAR OUTCOMES USING MYELOABLATIVE VERSUS REDUCED INTENSITY ALLOGENEIC TRANSPLANT PREPARATIVE REGIMENS FOR AML OR MDS

Por Luger, Selina M., Ringdén, Olle, Zhang, Mei-Jie, Pérez, Waleska S., Bishop, Michael R., Bornhauser, Martin, Bredeson, Christopher N., Cairo, Mitchell S., Copelan, Edward A., Gale, Robert Peter, Giralt, Sergio A., Gulbas, Zafer, Gupta, Vikas, Hale, Gregory A., Lazarus, Hillard M., Lewis, Victor Anthony, Lill, Michael C., McCarthy, Philip L., Weisdorf, Daniel J., Pulsipher, Michael A.
Publicado em 2011